스마트 진단 및 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유통 채널별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Smart Diagnostics & Monitoring Devices Market Summary

The global smart diagnostics and monitoring devices market size was estimated at USD 13.42 billion in 2024 and is projected to reach USD 26.14 billion by 2030, growing at a CAGR of 11.96% from 2025 to 2030. This growth is driven by the rising demand for real-time health monitoring and the increasing burden of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders.

The expanding adoption of blood glucose monitors, wearable ECGs, and smart thermometers reflects a broader shift toward personalized and preventive healthcare. Technological advancements, particularly in embedded sensors, AI-enabled analytics, and wireless connectivity, have enabled seamless integration of devices like smart clothing, contact lenses, and medical tricorders into consumer health ecosystems. The global increase in chronic conditions such as diabetes, hypertension, and cardiovascular diseases is a significant driver for the smart diagnostics and monitoring devices industry. These conditions require continuous management and monitoring, leading to a higher demand for advanced diagnostic tools. For instance, in December 2024, the World Health Organization reported that chronic diseases are responsible for 75% of all deaths globally, highlighting the urgent need for effective diagnostic and monitoring solutions.

The rising incidence of diabetes, driven by factors such as aging, obesity, and unhealthy lifestyles, is significantly the growth of the blood glucose monitoring devices market. Obesity, in particular, is a leading contributor to the development of diabetes. According to the World Health Organization (WHO), over 1 billion people will be classified as obese in 2022, including 650 million adults, 340 million adolescents, and 39 million children, a figure that continues to rise. If current trends continue, WHO projects that by 2025, around 167 million individuals, both adults and children, will face worsening health issues linked to excess weight.

Progress in mobile-based blood pressure monitoring technology is anticipated to fuel the market growth significantly. Companies are prioritizing the development of innovative, affordable, and easy-to-use solutions that meet the requirements of both patients and healthcare professionals. Enhancements in devices such as digital sphygmomanometers are central to this advancement. For instance, in July 2024, Smart Meter launched the first cellular-connected blood pressure monitor, tailored explicitly for remote patient monitoring and chronic care management through cellular networks.

Global Smart Diagnostics And Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global smart diagnostics and monitoring devices market report based on product, distribution channel, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Blood Glucose Monitors
• Pulse Oximeters
• Breath Analyzers
• Medical Tricorders
• Blood Pressure Monitors
• Smart Thermometers
• Heart Rate Monitors
• Smart Contact Lenses
  • Glucose Monitoring
  • Intraocular Pressure Monitoring
• Smart Clothing
  • Embedded Health Sensors
  • Fitness Monitoring
• Wearable ECG Monitors
  • Chest Straps
  • Patches
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmacies
• Online Channel
• Direct-to-Consumer (DTC)
• Others (Hypermarkets, Specialty Retailers)
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Clinics
• Home Care
• Others (Sports, Fitness Centers, Assisted Living)
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Distribution channel
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Distribution channel outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Smart Diagnostics and Monitoring Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Shift Toward Preventive and Personalized Healthcare
    • 3.2.1.2. Growth in Home Healthcare and Remote Monitoring
    • 3.2.1.3. Expanding Digital Health Ecosystem
    • 3.2.1.4. Consumerization of Healthcare and Fitness Monitoring
    • 3.2.1.5. Favorable Reimbursement and Regulatory Support
    • 3.2.1.6. Rising prevalence of chronic diseases
    • 3.2.1.7. Technological Advancements and Integration
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of standardization and regulation
    • 3.2.2.2. Data privacy and security concerns
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Smart Diagnostics and Monitoring Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape
• 3.4. Pricing Analysis
• 3.5. Covid-19 Impact

Chapter 4. Smart Diagnostics and Monitoring Devices Market: Product Estimates & Trend Analysis

• 4.1. Global Smart Diagnostics and Monitoring Devices Market: Product Dashboard
• 4.2. Product Market Share Analysis, 2024 & 2030
• 4.3. Smart Diagnostics and Monitoring Devices Market: By Product, 2018 to 2030
• 4.4. Blood Glucose Monitors
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Pulse Oximeters
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Breath Analyzers
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Medical Tricorders
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Blood Pressure Monitors
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Smart Thermometers
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Heart Rate Monitors
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Smart Contact Lenses
  • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11.2. Glucose Monitoring
    • 4.11.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11.3. Intraocular Pressure Monitoring
    • 4.11.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.12. Smart Clothing
  • 4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12.2. Embedded Health Sensors
    • 4.12.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12.3. Fitness Monitoring
    • 4.12.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.13. Wearable ECG Monitors
  • 4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.13.2. Chest Straps
    • 4.13.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.13.3. Patches
    • 4.13.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Smart Diagnostics and Monitoring Devices Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Global Smart Diagnostics and Monitoring Devices Market: Distribution Channel Dashboard
• 5.2. Distribution channel Market Share Analysis, 2024 & 2030
• 5.3. Smart Diagnostics and Monitoring Devices Market: By Distribution channel, 2018 to 2030
• 5.4. Pharmacies
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Online Channel
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Direct-to-Consumer (DTC)
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others (Hypermarkets, Specialty Retailers)
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Smart Diagnostics and Monitoring Devices Market: End Use Estimates & Trend Analysis

• 6.1. Global Smart Diagnostics and Monitoring Devices Market: End Use Dashboard
• 6.2. End Use Market Share Analysis, 2024 & 2030
• 6.3. Smart Diagnostics and Monitoring Devices Market: By End Use, 2018 to 2030
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Clinics
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Home Care
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others (Sports, Fitness Centers, Assisted Living)
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Smart Diagnostics and Monitoring Devices Market: Regional Estimates & Trend Analysis by product, distribution channel, and end use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Company Market Share Analysis, 2024
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles
  • 8.4.1. Abbott Laboratories
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Dexcom, Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. F. Hoffmann-La Roche Ltd
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Medtronic, plc.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Dragerwerk AG & Co. KGaA
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. LifeScan, Inc.
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. NeuroMetrix, Inc.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. OMRON Corporation
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Seer Medical
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. VitalConnect Inc.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. STRIDE BP
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. NIPRO CORPORATION
    • 8.4.12.1. Overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives